Dr. Stefan Aigner serves as Medical Advisor at Direct Allergy. He serves as Board Member at Cipher Pharmaceuticals. He is a founder of Inspirion Pharmaceuticals, LLC, a company formed in 2006 to pursue opportunities in the specialty pharmaceutical industry, and Inspirion Delivery Technologies, LLC, a company formed in 2008 to pursue abuse deterrent product development. From 2006 to 2008, Dr. Aigner was Executive Vice President, Corporate and Business Development at Alpharma, Inc., a global specialty pharmaceutical company. Before joining Alpharma, Dr. Aigner was co-founder and Executive Vice President of Business Development and Medical Affairs for Reliant Pharmaceuticals, Inc., a pharmaceutical company that specializes in the development, commercialization and marketing of prescription therapeutic products. During his tenure at Reliant, Dr. Aigner led the company through multiple acquisitions and significant in-licensing transactions and was responsible for building the company's cardiovascular portfolio through partnerships with leading U.S. and European companies. Prior to working at Reliant, he was a consultant with healthcare consulting firm The Wilkerson Group from 1996 to 1999. Dr. Aigner graduated summa cum laude with a degree in medicine from the University of Erlangen, Nuremberg, Germany.